Skip to main content
Top

21-01-2024 | Hashimoto Thyroiditis | Original Article

Are sonographic characteristics of Hashimoto’s thyroiditis related with immunologic parameters? A cross-sectional study

Authors: K. Kenarlı, A. B. Bahçecioğlu, Ö. B. Aksu, S. Güllü

Published in: Journal of Endocrinological Investigation

Login to get access

Abstract

Background

The clinical, laboratory, and imaging characteristics of Hashimoto’s thyroiditis are widely recognized. However, there is a dearth of information concerning the relationship between these aspects. The primary objective of this study was to investigate the correlation between sonographic features and immunologic parameters in individuals with Hashimoto’s thyroiditis.

Methods

This cross-sectional study enrolled a cohort of 100 consecutive patients diagnosed with Hashimoto’s thyroiditis. Ultrasonography was performed to classify thyroid gland characteristics, including parenchymal heterogeneity (mild/moderate-to-high), extent of fibrosis (none-to-mild/moderate-to-high), and volume (atrophic/non-atrophic). As for immunologic parameters, thyroid autoantibodies (TOA; anti-TPO and anti-Tg), along with IG (immunoglobulin) G4 levels and lymphocyte subsets, were assessed.

Results

Of the 100 patients evaluated, 88 were female (88%) and 12 were male (12%). IgG4/IgG ratio and weekly levothyroxine (LT4) dose were significantly higher in the group with moderate-to-high heterogeneity than the group with mild parenchymal heterogeneity (p = 0.043 and p < 0.001, respectively). Compared to the group with none-to-mild fibrosis, the anti-TPO, IgG4, IgG4/IgG ratio and LT4 dose were significantly higher in the moderate-to-high fibrosis group. Anti-TPO and IgG levels were significantly lower in the atrophic thyroid group compared to the non-atrophic thyroid group. Although not reaching statistical significance, the proportion of plasma cells in the moderate/high fibrosis group was higher than in the non-fibrosis/mild fibrosis group. There was a moderate positive correlation between fibrosis with Anti-TPO, and a low positive correlation between anti-Tg, IgG4 levels with IgG4/IgG ratio.

Conclusion

TOA, Ig G4 levels and severity of hypothyroidism were associated with ultrasonographic features such as parenchymal heterogeneity and fibrosis in Hashimoto’s thyroiditis.
Literature
1.
go back to reference Jacobson DL, Gange SJ, Rose NR, Graham NM (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84(3):223–243CrossRefPubMed Jacobson DL, Gange SJ, Rose NR, Graham NM (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84(3):223–243CrossRefPubMed
2.
go back to reference McLeod DS, Cooper DS (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2):252–265CrossRefPubMed McLeod DS, Cooper DS (2012) The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2):252–265CrossRefPubMed
5.
go back to reference Hayashi N, Tamaki N, Konishi J, Yonekura Y, Senda M, Kaeagi K et al (1986) Sonography of Hashimoto’s thyroiditis. J Clin Ultrasound 14(2):123–126CrossRefPubMed Hayashi N, Tamaki N, Konishi J, Yonekura Y, Senda M, Kaeagi K et al (1986) Sonography of Hashimoto’s thyroiditis. J Clin Ultrasound 14(2):123–126CrossRefPubMed
6.
go back to reference Sostre S, Reyes MM (1991) Sonographic diagnosis and grading of Hashimoto’s thyroiditis. J Endocrinol Invest 14(2):115–121CrossRefPubMed Sostre S, Reyes MM (1991) Sonographic diagnosis and grading of Hashimoto’s thyroiditis. J Endocrinol Invest 14(2):115–121CrossRefPubMed
7.
8.
go back to reference Li Y, Bai Y, Liu Z, Ozaki T, Taniguchi E, Mori I et al (2009) Immunohistochemistry of IgG4 can help subclassify Hashimoto’s autoimmune thyroiditis. Pathol Int 59(9):636–641CrossRefPubMed Li Y, Bai Y, Liu Z, Ozaki T, Taniguchi E, Mori I et al (2009) Immunohistochemistry of IgG4 can help subclassify Hashimoto’s autoimmune thyroiditis. Pathol Int 59(9):636–641CrossRefPubMed
9.
go back to reference Li Y, Nishihara E, Hirokawa M, Taniguchi E, Miyauchi A, Kakudo K (2010) Distinct clinical, serological, and sonographic characteristics of Hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab 95(3):1309–1317CrossRefPubMed Li Y, Nishihara E, Hirokawa M, Taniguchi E, Miyauchi A, Kakudo K (2010) Distinct clinical, serological, and sonographic characteristics of Hashimoto’s thyroiditis based with and without IgG4-positive plasma cells. J Clin Endocrinol Metab 95(3):1309–1317CrossRefPubMed
10.
go back to reference Li Y, Zhou G, Ozaki T, Nishihara E, Matsuzuka F, Bai Y et al (2012) Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod Pathol 25(8):1086–1097CrossRefPubMed Li Y, Zhou G, Ozaki T, Nishihara E, Matsuzuka F, Bai Y et al (2012) Distinct histopathological features of Hashimoto’s thyroiditis with respect to IgG4-related disease. Mod Pathol 25(8):1086–1097CrossRefPubMed
11.
go back to reference Kakudo K, Li Y, Taniguchi E, Mori I, Ozaki T, Nishihara E et al (2012) IgG4-related disease of the thyroid glands. Endocr J 59(4):273–281CrossRefPubMed Kakudo K, Li Y, Taniguchi E, Mori I, Ozaki T, Nishihara E et al (2012) IgG4-related disease of the thyroid glands. Endocr J 59(4):273–281CrossRefPubMed
12.
13.
go back to reference Nanba T, Watanabe M, Inoue N, Iwatani Y (2009) Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid 19(5):495–501CrossRefPubMed Nanba T, Watanabe M, Inoue N, Iwatani Y (2009) Increases of the Th1/Th2 cell ratio in severe Hashimoto’s disease and in the proportion of Th17 cells in intractable Graves’ disease. Thyroid 19(5):495–501CrossRefPubMed
14.
go back to reference Lintusaari J, Vesaniemi E, Kalfert D, Ilvesaro J, Ludvíková M, Kholová I (2020) IgG4-positive plasma cells in Hashimoto thyroiditis: IgG4-related disease or inflammation-related IgG4-positivity? APMIS 128(9):531–538CrossRefPubMed Lintusaari J, Vesaniemi E, Kalfert D, Ilvesaro J, Ludvíková M, Kholová I (2020) IgG4-positive plasma cells in Hashimoto thyroiditis: IgG4-related disease or inflammation-related IgG4-positivity? APMIS 128(9):531–538CrossRefPubMed
15.
go back to reference Rotondi M, Carbone A, Coperchini F, Fonte R, Chiovato L (2019) Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol 180(5):R175–R183CrossRefPubMed Rotondi M, Carbone A, Coperchini F, Fonte R, Chiovato L (2019) Diagnosis of endocrine disease: IgG4-related thyroid autoimmune disease. Eur J Endocrinol 180(5):R175–R183CrossRefPubMed
16.
go back to reference Deshpande V, Huck A, Ooi E, Stone JH, Faquin WC, Nielsen GP (2012) Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol 65(8):725–728CrossRefPubMed Deshpande V, Huck A, Ooi E, Stone JH, Faquin WC, Nielsen GP (2012) Fibrosing variant of Hashimoto thyroiditis is an IgG4 related disease. J Clin Pathol 65(8):725–728CrossRefPubMed
17.
go back to reference Zhang J, Zhao L, Gao Y, Liu M, Li T, Huang Y et al (2014) A classification of Hashimoto’s thyroiditis based on immunohistochemistry for IgG4 and IgG. Thyroid 24(2):364–370CrossRefPubMed Zhang J, Zhao L, Gao Y, Liu M, Li T, Huang Y et al (2014) A classification of Hashimoto’s thyroiditis based on immunohistochemistry for IgG4 and IgG. Thyroid 24(2):364–370CrossRefPubMed
18.
go back to reference Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH (2015) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74(1):14–18CrossRefPubMed Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH (2015) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74(1):14–18CrossRefPubMed
20.
go back to reference Jin M, Kim B, Jang A, Jeon MJ, Choi YJ, Lee YM et al (2022) Immunoglobulin G4-related thyroid disease: a single-center experience and literature review. Endocrinol Metab (Seoul) 37(2):312–322CrossRefPubMed Jin M, Kim B, Jang A, Jeon MJ, Choi YJ, Lee YM et al (2022) Immunoglobulin G4-related thyroid disease: a single-center experience and literature review. Endocrinol Metab (Seoul) 37(2):312–322CrossRefPubMed
21.
go back to reference Fink H, Hintze G (2010) Autoimmune thyroiditis (Hashimoto’s thyroiditis): current diagnostics and therapy. Med Klin (Munich) 105(7):485–493CrossRefPubMed Fink H, Hintze G (2010) Autoimmune thyroiditis (Hashimoto’s thyroiditis): current diagnostics and therapy. Med Klin (Munich) 105(7):485–493CrossRefPubMed
22.
go back to reference Park M, Park SH, Kim E-K, Yoon JH, Moon HJ, Lee HS et al (2013) Heterogeneous echogenicity of the underlying thyroid parenchyma: how does this affect the analysis of a thyroid nodule? BMC Cancer 13(1):550CrossRefPubMedPubMedCentral Park M, Park SH, Kim E-K, Yoon JH, Moon HJ, Lee HS et al (2013) Heterogeneous echogenicity of the underlying thyroid parenchyma: how does this affect the analysis of a thyroid nodule? BMC Cancer 13(1):550CrossRefPubMedPubMedCentral
23.
go back to reference Tam AA, Kaya C, Üçler R, Dirikoç A, Ersoy R, Çakır B (2015) Correlation of normal thyroid ultrasonography with thyroid tests. QIMS 5(4):569PubMedPubMedCentral Tam AA, Kaya C, Üçler R, Dirikoç A, Ersoy R, Çakır B (2015) Correlation of normal thyroid ultrasonography with thyroid tests. QIMS 5(4):569PubMedPubMedCentral
24.
go back to reference Brancatella A, Torregrossa L, Viola N, Sgrò D, Casula M, Basolo F et al (2023) In Graves’ disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features. J Endocrinol Invest 46:1–9CrossRef Brancatella A, Torregrossa L, Viola N, Sgrò D, Casula M, Basolo F et al (2023) In Graves’ disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features. J Endocrinol Invest 46:1–9CrossRef
25.
26.
go back to reference DeGroot LJ (2000) Graves’ disease and the manifestations of thyrotoxicosis. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K et al (eds) Endotext. MDText.com, Inc., South Dartmouth DeGroot LJ (2000) Graves’ disease and the manifestations of thyrotoxicosis. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dungan K et al (eds) Endotext. MDText.com, Inc., South Dartmouth
27.
go back to reference Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P et al (1993) Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77(6):1700–1705PubMed Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P et al (1993) Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77(6):1700–1705PubMed
28.
go back to reference Weetman AP (2003) Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 148(1):1–9CrossRefPubMed Weetman AP (2003) Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 148(1):1–9CrossRefPubMed
29.
go back to reference Mincer DL, Jialal I (2017) Hashimoto thyroiditis. StatPearls Publishing, Treasure Island Mincer DL, Jialal I (2017) Hashimoto thyroiditis. StatPearls Publishing, Treasure Island
30.
go back to reference Williams DE, Le SN, Godlewska M, Hoke DE, Buckle AM (2018) Thyroid peroxidase as an autoantigen in Hashimoto’s disease: structure, function, and antigenicity. Horm Metab Res 50(12):908–921CrossRefPubMed Williams DE, Le SN, Godlewska M, Hoke DE, Buckle AM (2018) Thyroid peroxidase as an autoantigen in Hashimoto’s disease: structure, function, and antigenicity. Horm Metab Res 50(12):908–921CrossRefPubMed
31.
go back to reference Bülow Pedersen I, Laurberg P, Knudsen N, Jørgensen T, Perrild H, Ovesen L et al (2005) A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure. Clin Endocrinol (Oxf) 62(6):713–720CrossRefPubMed Bülow Pedersen I, Laurberg P, Knudsen N, Jørgensen T, Perrild H, Ovesen L et al (2005) A population study of the association between thyroid autoantibodies in serum and abnormalities in thyroid function and structure. Clin Endocrinol (Oxf) 62(6):713–720CrossRefPubMed
32.
go back to reference Fenzi GF, Giani C, Ceccarelli P, Bartalena L, Macchia E, Aghini-Lombardi F et al (1986) Role of autoimmune and familial factors in goiter prevalence. Studies performed in a moderately endemic area. J Endocrinol Invest 9(2):161–164CrossRefPubMed Fenzi GF, Giani C, Ceccarelli P, Bartalena L, Macchia E, Aghini-Lombardi F et al (1986) Role of autoimmune and familial factors in goiter prevalence. Studies performed in a moderately endemic area. J Endocrinol Invest 9(2):161–164CrossRefPubMed
33.
go back to reference Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F et al (1999) The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84(2):561–566PubMed Aghini-Lombardi F, Antonangeli L, Martino E, Vitti P, Maccherini D, Leoli F et al (1999) The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab 84(2):561–566PubMed
34.
go back to reference Vanderpump M, Tunbrldge W, French J, Appleton D, Bates D, Clark F et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 43(1):55–68CrossRefPubMed Vanderpump M, Tunbrldge W, French J, Appleton D, Bates D, Clark F et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol (Oxf) 43(1):55–68CrossRefPubMed
35.
go back to reference Pusztaszeri M, Triponez F, Pache JC, Bongiovanni M (2012) Riedel’s thyroiditis with increased IgG4 plasma cells: evidence for an underlying IgG4-related sclerosing disease? Thyroid 22(9):964–968CrossRefPubMed Pusztaszeri M, Triponez F, Pache JC, Bongiovanni M (2012) Riedel’s thyroiditis with increased IgG4 plasma cells: evidence for an underlying IgG4-related sclerosing disease? Thyroid 22(9):964–968CrossRefPubMed
Metadata
Title
Are sonographic characteristics of Hashimoto’s thyroiditis related with immunologic parameters? A cross-sectional study
Authors
K. Kenarlı
A. B. Bahçecioğlu
Ö. B. Aksu
S. Güllü
Publication date
21-01-2024
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-023-02286-y
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare